- Home
- RCMT vs FDMT Comparison
RCMT vs FDMT Comparison
Compare RCMT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- FDMT
- Stock Information
- Founded
- RCMT 1971
- FDMT 2013
- Country
- RCMT United States
- FDMT United States
- Employees
- RCMT N/A
- FDMT N/A
- Industry
- RCMT Professional Services
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- RCMT Consumer Discretionary
- FDMT Health Care
- Exchange
- RCMT Nasdaq
- FDMT Nasdaq
- Market Cap
- RCMT 172.2M
- FDMT 192.2M
- IPO Year
- RCMT N/A
- FDMT 2020
- Fundamental
- Price
- RCMT $24.60
- FDMT $4.32
- Analyst Decision
- RCMT Strong Buy
- FDMT Buy
- Analyst Count
- RCMT 2
- FDMT 10
- Target Price
- RCMT $33.50
- FDMT $32.33
- AVG Volume (30 Days)
- RCMT 81.1K
- FDMT 418.9K
- Earning Date
- RCMT 08-06-2025
- FDMT 08-07-2025
- Dividend Yield
- RCMT N/A
- FDMT N/A
- EPS Growth
- RCMT N/A
- FDMT N/A
- EPS
- RCMT 1.74
- FDMT N/A
- Revenue
- RCMT $290,914,000.00
- FDMT $23,000.00
- Revenue This Year
- RCMT $16.29
- FDMT $13,048.65
- Revenue Next Year
- RCMT $6.16
- FDMT N/A
- P/E Ratio
- RCMT $14.17
- FDMT N/A
- Revenue Growth
- RCMT 8.53
- FDMT N/A
- 52 Week Low
- RCMT $13.18
- FDMT $2.24
- 52 Week High
- RCMT $27.24
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- RCMT 55.47
- FDMT 57.43
- Support Level
- RCMT $22.48
- FDMT $3.86
- Resistance Level
- RCMT $27.24
- FDMT $4.48
- Average True Range (ATR)
- RCMT 1.22
- FDMT 0.28
- MACD
- RCMT 0.04
- FDMT 0.01
- Stochastic Oscillator
- RCMT 62.07
- FDMT 89.81
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.